Aspen Global Inc. and Johnson & Johnson have announced that they will provide 300,000 doses of J&J’s COVID-19 vaccine for South African teachers and support vaccination programmes in South Africa and elsewhere in Africa, after facing a production setback.
The vaccination support was announced by Aspen after learning that specific batches of the J&J COVID-19 vaccine manufactured at Aspen’s Gqeberha production site and designated for the South African market had to be destroyed due to a good manufacturing practice risk linked to isolated material in the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?